Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly
Clinical trial NCT02147548 · COMPLETED
Trial details
- NCT number
- NCT02147548
- Sponsor
- Biocodex
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-10-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.